General - Press Releases

Date	Title	Company
12-Sep-2022	GenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe	Businesswire
12-Sep-2022	Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region	Businesswire
11-Sep-2022	Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022	Businesswire
11-Sep-2022	Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC)	Businesswire
10-Sep-2022	Bicara Therapeutics Presents New Data from Ongoing Phase 1/1b Trial of Lead First-in-Class Bifunctional Program, BCA101, at the European Society for Medical Oncology (ESMO) Congress 2022	Businesswire
10-Sep-2022	Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022	Businesswire
10-Sep-2022	Exelixis Announces Dose-Escalation Results from the Phase 1 STELLAR-001 Trial Evaluating XL092 Alone and in Combination with an Immune Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ESMO 2022	Businesswire
10-Sep-2022	Wugen Presents Preclinical Data on WU-NK-101 in Solid Tumor Models at the European Society for Medical Oncology (ESMO) Congress 2022	Businesswire
10-Sep-2022	BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer	Businesswire
10-Sep-2022	Bristol Myers Squibb Announces New Sotyktu™ (deucravacitinib) Long-Term Data Showing Clinical Efficacy Maintained for Up to Two Years with Continuous Treatment in Moderate-to-Severe Plaque Psoriasis	Businesswire
10-Sep-2022	U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis	Businesswire
10-Sep-2022	MarketVector Indexes™ Announces Quarterly and Semi-Annual Index Review Results for Q3 2022	Businesswire
10-Sep-2022	Antibe Announces Results of 2022 Annual Meeting	Businesswire
09-Sep-2022	Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection	Businesswire
09-Sep-2022	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Businesswire
09-Sep-2022	Global Irritable Bowel Syndrome with Constipation Drugs Market Report to 2030 - Featuring Abbott Laboratories, AstraZeneca and Sanofi Among Others - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Outlook on the Smart Manufacturing Global Market to 2028 - Featuring ABB, Honeywell International, Rockwell Automation and Siemens Among Others - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Americas Pipe Insulation Market to Reach $3.91 Billion by 2030 - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Global Empty Capsules Market Report 2022: Development of Halal Gelatin Capsules Presents Opportunities - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Global Advanced Drug Delivery Systems Market Report 2022: Development and Advancement of Formulations and Technologies Such as Modified-Release Technologies Driving Growth - ResearchAndMarkets.com	Businesswire